Browse By Topic Clinical Microbiology
ASM hails the inclusion of $1.75 billion for CDC’s Advanced Molecular Detection (AMD) program in the American Rescue Plan Act signed into law by President Biden.
ASM responds to the House Energy & Commerce Subcommittee on Health Hearing: “Road to Recovery: Ramping Up COVID-19 Vaccines, Testing and Medical Supply Chain."
The shortage of laboratory supplies associated with the high demand for COVID-19 testing have been continuously impacting the laboratory supply chain since the early days of the pandemic. Now, new reports of concerning and unprecedented supply shortages for non-COVID-19-related tests are emerging and affecting diagnostic testing for a variety of other diseases.